$500 into $678,906?
If you had followed Jay Soloff’s 2018 trades, with a little luck, you could’ve turned $500 into as much as $678,906. That sounds unbelievable. But… Read More »$500 into $678,906?
If you had followed Jay Soloff’s 2018 trades, with a little luck, you could’ve turned $500 into as much as $678,906. That sounds unbelievable. But… Read More »$500 into $678,906?
The most recent Fortune 500 list of the largest U.S. companies by revenue includes a record 33 companies led by female CEOs. Here are eight… Read More »Female CEOs Are Leading These Stocks Higher
The only way to generate market-beating returns is to hold stocks with higher systemic risk…right? That’s what modern portfolio theory, conventional Wall Street wisdom and… Read More »Factor Investing And The Risk/Reward Tradeoff
With one forecast predicting that cannabidiol sales in the U.S. will soar to $22 billion by 2022, it is no wonder that CBD is garnering… Read More »A Sneakier, Smarter, And More Stable CBD Play
While it’s currently a small subset of the real estate sector, this “cold” investment is really heating up thanks to food delivery services such as… Read More »A “Cold” Investment That’s Heating Up
With Ellevest, her investing platform for women, former Wall Street executive Sallie Krawcheck is on a mission to help women gain control over their financial… Read More »Ellevest-ing: How Women Can Get Their Fair Share
They have the potential to be as revolutionary to the cannabis industry as automated teller machines were to the banking industry: cannabis kiosks (or “pot-bots”)… Read More »Investing In The Rise Of The “Pot-Bots”
When it comes to finding sources of strong returns among healthcare stocks, investors may be better off focusing on businesses rather than potential breakthroughs. In… Read More »Healthcare Stocks: Business Over Breakthrough
How do you trade during a trade war? Here are some thoughts on everything from strategy, commodities, penny stocks – and being careful with overnight… Read More »Trading And The Trade War
Healthcare stocks have lagged overall this year, in large part due to political and regulatory risks. Some healthcare stocks, however, appear to be shielded from… Read More »Healthcare Stocks With Political Immunity